IHS Chemical Week
M&A

Axiall sells phosgenes facility in Texas

11:20 AM MST | February 26, 2015 | Vincent Valk

Axiall today announced it has sold its phosgene and derivatives facility at LaPorte, TX to Altivia Chemicals (Houston) for an undisclosed sum. The facility makes phosgene and derivatives for use in the polymer, pharma, and agchems industries. It is the...


Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com
MORE M&A

JSR Corp. acquires contract manufacturing group KBI Biopharma

JSR Corp. along with CMIC Holdings Co. (Tokyo) and Innovation Network Corporation of Japan (INCJ), announced today that they have agreed to acquire KBI Biopharma, a biopharmaceutical contract development and manufacturing organization with facilities at...

Bayer reports improved results, will decide on either a spinoff or IPO of MaterialScience

Bayer today reported a 7.4% rise in 2014 net income to €3.43 billion ($3.89 billion) on 5.2% higher sales of €42.24 billion. Adjusted for currency and portfolio effects, sales grew by 7.2%.  All subgroups contributed to this increase, the...

Private equity firm Apax Partners confirms acquisition of specialties distributor Azelis

Private equity company Apax Partners has signed a binding agreement to acquire specialty chemicals distributor Azelis (Antwerp) from another private equity firm, 3i Group. Apax and 3i announced earlier this month that they had entered into exclusive...

Valeant Pharma to acquire Salix Pharma in $14.5-billion deal

Valeant Pharmaceuticals International (Laval, PC) said on Sunday that it has entered into a definitive agreement with Salix Pharmaceuticals (Raleigh, NC) under which Valeant will acquire all of the outstanding common stock of Salix for $158.00/share in cash...

Oiltanking sells minority stakes in two European terminals to investment firm

Oiltanking (Hamburg) says that it has agreed to divest stakes of 45% in two of the company's tank storage terminals in northwest Europe, to 3i Infrastructure. The terminals are at Terneuzen, Netherlands and Ghent, Belgium. Financial terms of the deal have not...

Cipla UK forms JV in Morocco, will invest in new plant

Cipla (Mumbai), a global pharma company, today announced that its wholly owned, UK-based subsidiary, Cipla (EU) Ltd, has entered into a joint venture agreement with Cipla’s existing business partners in Morocco, Societe Marocaine de Cooperation...

Platform closes Arysta LifeScience acquisition

Blank-check firm Platform Specialty Products (Miami) today closed the acquisition of agchems company Arysta LifeScience (Dublin) from private equity firm Permira (London) for $3.51 billion. The purchase price includes $2.91 billion in cash and $600.0 million...

Rentech Nitrogen retains bank to 'explore strategic alternatives'

Rentech Nitrogen Partners’ board says it has retained Morgan Stanley (New York), an investment bank, in an effort to consider “strategic alternatives” for the company, including a sale, merger, or other transaction. The company has not set a...

Bayer to reorganize life sciences businesses after BMS separation

Bayer is planning to reorganize its life science businesses, which include its health-care and crop science businesses, in anticipation of the separation of Bayer MaterialScience (BMS), which expected by early 2016, reports say. BMS, Bayer’s...

M&A Archives »











 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa